BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 17433034)

  • 1. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.
    Klatte T; Wunderlich H; Patard JJ; Kleid MD; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
    BJU Int; 2007 Jul; 100(1):21-5. PubMed ID: 17433034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
    Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
    Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients.
    Klatte T; Seitz C; Waldert M; de Martino M; Kikic Z; Böhmig GA; Haitel A; Schmidbauer J; Marberger M; Remzi M
    BJU Int; 2010 May; 105(9):1260-5. PubMed ID: 19818071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.
    Takagi T; Kondo T; Izuka J; Kobayashi H; Tomita E; Hashimoto Y; Tanabe K
    Int J Urol; 2011 Dec; 18(12):806-12. PubMed ID: 21917022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy.
    Zubac DP; Bostad L; Gestblom C; Kihl B; Seidal T; Wentzel-Larsen T; Bakke AM
    Scand J Urol Nephrol; 2007; 41(3):191-7. PubMed ID: 17469026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathobiology and prognosis of chromophobe renal cell carcinoma.
    Klatte T; Han KR; Said JW; Böhm M; Allhoff EP; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    Urol Oncol; 2008; 26(6):604-9. PubMed ID: 18367104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contralateral metachronous tumor occurrence is more frequently associated with distant metastases or postoperative intrarenal recurrence in renal cell carcinoma patients.
    Amano H; Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Shimada K; Nakazawa H; Ito F; Tanabe K
    Int J Urol; 2010 Jul; 17(7):615-22. PubMed ID: 20482658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy.
    Simhan J; Canter DJ; Sterious SN; Smaldone MC; Tsai KJ; Li T; Viterbo R; Chen DY; Greenberg RE; Kutikov A; Uzzo RG
    J Urol; 2013 Jan; 189(1):43-7. PubMed ID: 23164383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
    Denzinger S; Otto W; Burger M; Hammerschmied C; Junker K; Hartmann A; Wieland WF; Walter B
    World J Surg Oncol; 2007 Feb; 5():16. PubMed ID: 17280613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.
    Gillett MD; Cheville JC; Karnes RJ; Lohse CM; Kwon ED; Leibovich BC; Zincke H; Blute ML
    J Urol; 2005 Jun; 173(6):1893-6. PubMed ID: 15879770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.
    Klatte T; Patard JJ; Wunderlich H; Goel RH; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
    J Urol; 2007 Jun; 177(6):2081-6; discussion 2086-7. PubMed ID: 17509291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.